Autopsy report · NCT03332082

A Commercial Available Tooth Positioner for the Treatment of Simple Orthodontic Relapse

“losing of funding for the study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

University of Alabama at Birmingham

Sponsor type

University, hospital or other

Conditions

Orthodontics; Orthodontic Appliance

Interventions

Tooth positioner

Participants

0

Trials that died the same way

• Pharmacogenetic Testing for Medication Management.
  “Loss of funding for the continuation of the Study” (91% match in meaning)
• Abuse Potential of Buprenorphine/Naloxone
  “Funding ended for the study” (81% match in meaning)
• UNTIRE: Cancer-related Fatigue With Digital Treatment
  “loss of funding” (81% match in meaning)
• Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction
  “Lost funding for Phase II portion of study” (80% match in meaning)
• Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures
  “Lack of funding to support the study” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.